华东医药:2025年第一季度报告(英文版)

Stock code: 000963 Stock abbreviation: Huadong Medicine Announcement No.: 2025-036
Huadong Medicine Co., Ltd.
First Quarterly Report 2025
The Company and all members of the Board of Directors hereby guarantee that the information presented in
this report is authentic, accurate, complete, and free of any false records, misleading statements or material
omissions.
Important Declaration:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management of Huadong Medicine Co., Ltd.
(hereinafterreferred to asthe“Company”) herebyguaranteethat theinformationpresentedinthisreport is authentic, accurate, complete,
and free of any false records, misleading statements or material omissions, and shall undertake individual and joint legal liabilities.
2.TheCompany’slegal representative, theofficer in chargeofaccounting, and thehead ofaccountingdepartment (accountingmanager)
hereby declare that the financial information in this quarterly report is authentic, accurate, and complete.
3. Has the First Quarterly Report been audited
□Yes No
According to “Stock Listing Rules of the Shenzhen Stock Exchange”, if listed companies have both Chinese and
other language version of public notice, they should ensure the content of both versions are the same. In the case
of discrepancy, the original version in Chinese shall prevail.
I. Key Financial Data
(I) Key accounting data and financial indicators
Whether the Company needs to perform a retroactive adjustment or restatement of previous accounting data
□Yes No
……